Results 361 to 370 of about 14,957,077 (381)

CAR T Cells for Neuroblastoma

New England Journal of Medicine, 2023
Oladapo O. Yeku, Dan L. Longo
openaire   +2 more sources

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells

Nature Medicine, 2018
M. Norelli, B. Camisa, G. Barbiera, Laura Falcone, Ayurzana Purevdorj, M. Genua, F. Sanvito, M. Ponzoni, C. Doglioni, P. Cristofori, C. Traversari, C. Bordignon, F. Ciceri, Renato Ostuni, C. Bonini, M. Casucci, A. Bondanza   +16 more
semanticscholar   +1 more source

GPC3-CAR-T

Reactions Weekly, 2023
openaire   +1 more source

CAR-T Therapy

2022
Rucker, Brayden, Muhammad, Rohaan, Kee, Micah Daniel, Garrett, Morgan, Fitzgerald, Kyle, Flores, Holly, Wise, Audrey   +6 more
openaire   +1 more source

CAR-T cells tackle autoimmunity

Nature Biotechnology, 2022
openaire   +2 more sources

CAR T cells beyond cancer

Nature Medicine, 2022
openaire   +2 more sources

CAR-T Cells

Clinical Lymphoma Myeloma and Leukemia, 2019
openaire   +1 more source

CAR T cells show activity

Nature Reviews Clinical Oncology, 2022
openaire   +2 more sources

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

Nature Medicine
David M. Cordas dos Santos, Tobias Tix, R. Shouval, A. Gafter-Gvili, Jean-Baptiste Alberge, E. Cliff, Sebastian Theurich, Michael von Bergwelt-Baildon, I. Ghobrial, M. Subklewe, M. Perales, K. Rejeski   +11 more
semanticscholar   +1 more source

Unanswered questions following reports of secondary malignancies after CAR-T cell therapy

Nature Medicine
Bruce L. Levine, M. Pasquini, John E Connolly, David L. Porter, Michael P Gustafson, J. Boelens, Edwin M. Horwitz, Stephan A. Grupp, M. Maus, F. Locke, F. Ciceri, A. Ruggeri, J. Snowden, Helen E. Heslop, Crystal L. Mackall, Carl H. June, A. Sureda, M. Perales   +17 more
semanticscholar   +1 more source